KR20190036330A - Anti-oxidant Composition Comprising Heated Radish Extract - Google Patents
Anti-oxidant Composition Comprising Heated Radish Extract Download PDFInfo
- Publication number
- KR20190036330A KR20190036330A KR1020170125436A KR20170125436A KR20190036330A KR 20190036330 A KR20190036330 A KR 20190036330A KR 1020170125436 A KR1020170125436 A KR 1020170125436A KR 20170125436 A KR20170125436 A KR 20170125436A KR 20190036330 A KR20190036330 A KR 20190036330A
- Authority
- KR
- South Korea
- Prior art keywords
- radish
- extract
- heat
- antioxidant
- treated
- Prior art date
Links
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 22
- 229940092385 radish extract Drugs 0.000 title abstract description 7
- 235000006708 antioxidants Nutrition 0.000 title description 12
- 241000220259 Raphanus Species 0.000 claims abstract description 36
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 36
- 238000010438 heat treatment Methods 0.000 claims abstract description 30
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 239000002537 cosmetic Substances 0.000 claims abstract description 8
- 239000000284 extract Substances 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 230000032683 aging Effects 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 208000024827 Alzheimer disease Diseases 0.000 claims description 2
- 206010002383 Angina Pectoris Diseases 0.000 claims description 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 2
- 208000014644 Brain disease Diseases 0.000 claims description 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 2
- 208000007882 Gastritis Diseases 0.000 claims description 2
- 208000023105 Huntington disease Diseases 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 208000012902 Nervous system disease Diseases 0.000 claims description 2
- 208000025966 Neurological disease Diseases 0.000 claims description 2
- 208000018737 Parkinson disease Diseases 0.000 claims description 2
- 208000034189 Sclerosis Diseases 0.000 claims description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 2
- 201000008937 atopic dermatitis Diseases 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 208000029078 coronary artery disease Diseases 0.000 claims description 2
- 230000003412 degenerative effect Effects 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 claims description 2
- 206010017758 gastric cancer Diseases 0.000 claims description 2
- 208000006454 hepatitis Diseases 0.000 claims description 2
- 231100000283 hepatitis Toxicity 0.000 claims description 2
- 230000000302 ischemic effect Effects 0.000 claims description 2
- 208000032839 leukemia Diseases 0.000 claims description 2
- 208000010125 myocardial infarction Diseases 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
- 201000011549 stomach cancer Diseases 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 2
- 241001131796 Botaurus stellaris Species 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 230000003143 atherosclerotic effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 7
- 238000000605 extraction Methods 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 230000002292 Radical scavenging effect Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 4
- 238000004042 decolorization Methods 0.000 description 4
- -1 hydroxyl radicals Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000011293 Brassica napus Nutrition 0.000 description 3
- 240000008100 Brassica rapa Species 0.000 description 3
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000003763 carbonization Methods 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 239000004159 Potassium persulphate Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000019057 Raphanus caudatus Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000011380 Raphanus sativus Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940105657 catalase Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
Description
본 발명은 무의 항산화 활성을 증가시킬 수 있도록 가공처리된 무 추출물을 포함하는 항산화 조성물에 관한 것이다. The present invention relates to an antioxidative composition comprising a radish extract which has been processed so as to increase the antioxidative activity of radish.
무(Radish, Raphanus sativus L.)는 십자화과(Cruciferae) 채소로 휘발성 함황 성분을 가지고 있어 독특한 매운 맛을 지니고 있다. 무의 독특한 매운 맛은 무에 함유된 티오글루코사이드가 잘리거나 세포가 파괴되었을 때 자체 내에 있는 글루코사이다아제라는 효소에 의하여 티오시아네이트와 이소티오시아네이트로 분리되는 것에 의한다. 우리나라에는 불교의 전래와 함께 삼국시대에 재배되기 시작하였으며, 우리나라 채소 중 재배면적이 가장 커서 5만㏊에 달하고 있으며 연간 생산량도 220만톤에 이르고 있다. 무는 김치, 깍두기, 무말랭이, 단무지와 같은 반찬 뿐 아니라 국이나 찌개, 조림에서도 감칠맛을 내기 때문에 그 이용이 매우 다양하다.Radish ( Raphanus sativus L.) is a Cruciferae vegetable with a volatile sulfur component that has a distinctive spicy taste. The unique pungent flavor of radish is due to the fact that when the thioglucoside contained in radish is cut off or when the cells are destroyed, the glucosidase enzyme is separated into thiocyanate and isothiocyanate by the enzyme. In Korea, it was cultivated in the Three Kingdoms period with the introduction of Buddhism. The largest cultivation area of Korean vegetables is 50,000 ㏊, and its annual production reaches 2.2 million tons. There are a lot of uses such as kimchi, kakdugi, halibut, and radish, as well as soup, stew, and simmered rice.
무에는 다른 채소에 비해 유리아미노산, 당, 칼슘 및 인 등이 많이 함유되어 있다. 뿌리에 함유된 당분은 주로 포도당, 과당이고 이외에 쿠마르산, 카페인산(caffeic acid), 페룰린산(ferulic acid), 페닐피루빈산(phenylpyruvic acid), 젠티딘산(gentidin acid), 히드록시 안식향산 및 다종의 아미노산이 함유되어 있다. 특히, 비타민 C의 함량이 20∼25㎎이나 되어 예로부터 겨울철 비타민 공급원으로 중요한 역할을 해왔다. 무 뿌리인 나복(羅蔔)은 가래, 기침해소, 이질 등에 효과가 있고, 어패류 또는 면류의 중독을 해소하는데도 효과가 있다고 고전에 기록되어 있다. 무에 함유된 디아스타제(diastase)는 소화촉진, 식중독, 숙취해소에 효과가 있으며 라핀(rapine)은 세균, 진균, 기생충 등에 대한 항균 작용이 있는 성분으로 알려져 있다. Compared to other vegetables, radish contains a lot of free amino acids, sugars, calcium and phosphorus. The sugars contained in the roots are mainly glucose and fructose, and in addition to cucuronic acid, caffeic acid, ferulic acid, phenylpyruvic acid, gentidin acid, hydroxybenzoic acid, Of amino acids. In particular, the vitamin C content of 20 ~ 25mg has been playing an important role as a vitamin source in winter. Nopokunu (羅 무) is effective in eliminating sputum, coughing, and dysentery, and has been recorded in classics as being effective in eliminating poisoning from fish and shellfish or noodles. Diastase in radish is effective in promoting digestion, food poisoning and hangovers, and rapine is known to be an antimicrobial ingredient for bacteria, fungi and parasites.
인체에는 항산화 물질(라디칼 소거제)인 슈퍼옥사이드 디스뮤타제 (SuperOxide Dismutase : SOD), 카탈라아제, 비타민 E, 비타민 C, 유비퀴놀 (Uviquinol)이 있지만, 나이, 공해, 자외선, 스트레스에 의해 항산화 체계가 무력화되고, 수퍼옥사이드라디칼, 하이드록시 라디칼, 과산화수소, 일중항산소와 같은 반응성이 매우 큰 활성산소의 농도가 증가하며 생체에 치명적인 산소독성을 일으키게 된다. 따라서 이와 같은 활성산소를 소거할 수 있는 화합물 또는 과산화물 생성 억제물질과 같은 항산화제는 이들 산화물들에 의하여 야기되는 각종 질환 치료제 및 노화억제제로서 기대된다. 또한 식품의 산패로 인한 식품의 영양가 및 품질의 저하를 억제하는 항산화제로서 의약산업, 농업, 식품공업 등 다방면으로 이용될 수 있다.There are superoxide dismutase (SOD), catalase, vitamin E, vitamin C and ubiquinol, which are antioxidants (radical scavenging agents) in the human body. And the concentration of reactive oxygen, such as superoxide radicals, hydroxyl radicals, hydrogen peroxide, and singlet oxygen, which are highly reactive, is increased, resulting in lethal oxygen toxicity in the living body. Therefore, such an antioxidant such as a compound capable of scavenging active oxygen or a peroxide formation inhibiting substance is expected as a therapeutic agent for various diseases and an aging inhibitor caused by these oxides. In addition, it can be used in various fields such as medicine industry, agriculture, food industry as an antioxidant which suppresses deterioration of nutritive value and quality of food due to rancidity of food.
무는 항산화 특성을 나타내어 이를 활용하기 위한 특허들 역시 등록 되었는데, 등록특허 제10-1706817호는 무청 추출물을 포함하는 항염 및 항산화를 위한 동물사료 조성물을, 등록특허 제10-1338190호는 보르도 무 마쇄액을 함유하는 항산화 및 혈전증 예방 또는 식품 및 약학 조성물을, 등록특허 제10-1685251호는 순무, 순무 무청 또는 순무 캘러스의 추출물을 유효성분으로 포함하는 항산화, 피부수렴 및 주름개선용 화장료 조성물 및 이의 제조방법을 게시하였다.Patent No. 10-1706817 discloses an animal feed composition for anti-inflammation and antioxidation, which contains an extract of Wuchuan, and Patent No. 10-1338190 discloses an animal feed composition for anti-inflammation and antioxidation, And a composition for preventing and treating thrombosis or a food and a pharmaceutical composition, and a composition for improving antioxidant, skin convergence and wrinkle comprising the extract of turnips, turnip mung bean or turnip callus as an active ingredient, and a preparation thereof Method.
무의 껍질과 무청은 식용으로 사용하기도 하지만, 질기고 거친 식감으로 인하여 제거 후 식용하는 경우가 많아 부산물로서 폐기되거나 가축의 사료로 이용되는 실정이다. 본 발명자들은 무의 생리 활성을 더욱 증가시킬 수 있는 가공방법에 대해 연구하던 중 상기 부산물을 포함한 무의 간단한 처리 공정에 의해 항산화 특성이 현저하게 증가할 수 있음을 확인하고 본 발명을 완성하였다.The radish peel and mulberry are used for edible purposes, but they are frequently used as a by-product for disposal or as feed for livestock. The inventors of the present invention have investigated a processing method capable of further increasing the physiological activity of radish, and confirmed that the antioxidative properties can be remarkably increased by the simple treatment of radish, including the by-products, and completed the present invention.
본 발명은 무의 항산화성을 증가시키기 위한 가공공정을 포함하여, 의약품이나 화장품 및 식품 분야에 활용할 수 있는 항산화성이 우수한 조성물을 제공하는 것을 목적으로 한다. It is an object of the present invention to provide a composition having excellent antioxidative properties, which can be utilized in medicines, cosmetics and foods, including a processing step for increasing antioxidative activity of radish.
전술한 목적을 달성하기 위한 본 발명은 100~200℃에서 열처리한 무의 추출물을 포함하는 항산화 약학 조성물에 관한 것이다. In order to accomplish the above object, the present invention relates to an antioxidant pharmaceutical composition comprising a radish extract which is heat-treated at 100 to 200 ° C.
상기 열처리는 무에 열을 가하는 것으로, 열처리 온도가 높을수록 항산화능이 증가하기 때문에 가급적 높은 온도에서 처리하는 것이 바람직하지만 온도가 높아지면 탄화가 일어날 수 있기 때문에 110~150℃의 온도에서 처리하는 것이 더욱 바람직하다. 무를 열처리 하는 것에 의해 추출물의 수율이 증가하고, 폴리페놀 함량이나 DPPH 라디칼 소거능, ABTS cation decolorization assay로 평가한 항산화능이 현저하게 증가하였다.Since the heat treatment increases the antioxidative ability as the heat treatment temperature is increased, it is preferable to treat at a high temperature as much as possible. However, since the carbonization may occur at a higher temperature, it is more preferable to treat at a temperature of 110 to 150 ° C desirable. The heat treatment of radish increased the yield of the extract and the antioxidant activity of polyphenol content, DPPH radical scavenging ability and ABTS cation decolorization assay.
상기 무는 생것이나, 건조물 또는 동결물 등 어떤 형태를 사용하여도 무방하다. 무는 수분이 많기 때문에 무를 생것인 상태 또는 동결물의 상태로 열처리 하는 경우에는 별도의 물을 추가하지 않아도 무 자체의 수분이 있으므로 상기 온도에서 열처리하는 경우에는 고압의 조건이 필요하다. 또한 상기 열처리 과정에서 무가 자숙된다. 그러나 건조된 무를 사용하여 상기 온도에서 열처리하는 경우에는 열처리 과정에서 탄화될 수 있으므로, 건조된 무를 물에 불려서 처리하거나 혹은 소량의 물을 첨가하여 열처리하는 것이 바람직하다. Any form such as frozen raw, dried or frozen may be used. When the heat is applied to the frosted state or the frosted state, since there is a large amount of moisture, there is moisture of the frosted body without adding any additional water. Further, the substrate is immersed in the heat treatment process. However, when the dried radish is heat-treated at the above-mentioned temperature, it can be carbonized in the heat-treatment process. Therefore, it is preferable to treat the dried radish with water or heat treatment with a small amount of water.
상기 무는 무의 뿌리 또는 무청 또는 이들의 혼합물일 수 있다. 무와 무청은 깨끗이 세척하여 오염된 부분을 제거한 후 사용하며, 통째로 혹은 적절한 크기로 절단하여 사용할 수 있다. 너무 작은 크기로 절단하여 사용하는 경우에는, 열처리 과정에서 유용물질이 유출될 수 있으므로 유용물질의 유출을 방지할 수 있도록 용기에 담아 처리하는 것이 좋다.The radish may be a radish root or a mixture thereof or a mixture thereof. It can be used after removing the contaminated part by washing it cleanly, and cutting it whole or in an appropriate size. In case of cutting to a too small size, since the useful substance may leak out during the heat treatment process, it is preferable to treat the product in a container so as to prevent leakage of the useful substance.
열처리 시간은 시료의 크기나 열처리 온도를 고려하여 10분~6시간 처리하는 것이 바람직하다. 시료의 크기가 클수록, 열처리 온도가 낮을수록 열처리 시간이 길어짐은 당연하다. The heat treatment time is preferably 10 minutes to 6 hours in consideration of the size of the sample and the heat treatment temperature. It is natural that the larger the sample size and the lower the heat treatment temperature, the longer the heat treatment time.
본 발명에서 열처리한 무의 추출물은 열처리한 무를 그대로 착즙하거나 별도의 용매를 사용하여 수득할 수 있다. 별도의 용매를 사용하여 추출하는 경우, 용매는 물이나 C1~C4의 저급 알콜 또는 이들의 혼합물을 사용할 수 있다. 용매를 사용한 추출 시 열처리한 무는 추출이 용이하도록 분쇄 또는 마쇄하여 추출하는 것이 더욱 바람직하다. 추출은 당업계에서 천연물의 추출에 사용되는 방법 중 어느 것을 사용하여도 무방하며, 예를 들면 냉침, 열추출, 초음파추출 등을 사용할 수 있으나 이에 한정되는 것은 아니다. 착즙이나 용매를 사용한 추출에 의해 얻어진 추출물은 그 자체로 사용하거나, 농축하거나, 건조하여 사용할 수 있다. 건조방법 역시 분무건조, 열건조, 동결건조 등 통상의 방법을 사용할 수 있음은 당연하다.In the present invention, the extract of radish which has been heat-treated can be obtained by either squeezing the heat-treated radish or using a separate solvent. When extracting using a separate solvent, water, C1-C4 lower alcohol or a mixture thereof may be used as the solvent. It is more preferable to perform pulverization or pulverization so as to facilitate the extraction of the heat-treated rice upon extraction with a solvent. Any of the methods used in the art for extracting natural products may be used for the extraction, and for example, cold-water extraction, heat extraction, ultrasonic extraction, etc. may be used, but the present invention is not limited thereto. The extract obtained by extraction using a juice or a solvent can be used as such, concentrated, or dried. It is a matter of course that conventional drying methods such as spray drying, thermal drying and freeze drying can be used.
본 발명의 조성물은 치료용 약제로 이용하기 위해서 약제학적 분야에서 공지의 방법에 의하여 제조될 수 있으며, 그 자체 또는 약학적으로 허용되는 담체(carrier), 부형제(forming agent), 희석제 등과 혼합하여 사용될 수 있다. 본 발명의 조성물은 경구 또는 비경구 투여용 제제로 제형화하여 활성산소로 인해 발생하는 질병 및 노화의 예방 및 치료제로 사용할 수 있다. 상기 활성산소로 인해 발생하는 질병으로는 동맥경화증, 루게릭병, 파킨슨병, 알츠하이머, 근위축색경화증 및 헌팅톤병을 포함하는 퇴행성 신경질환, 심근경색, 협심증, 관상동맥질환, 허혈성 심장질환을 포함하는 심혈관 질환, 뇌졸중을 포함하는 허혈성 뇌질환, 당뇨병, 위염 및 위암을 포함하는 소화기계 질환, 암, 백혈병, 노화, 류마티스 관절염, 간염, 아토피성 피부염 등을 예로 들 수 있으나 이에 한정되는 것은 아니다.The composition of the present invention may be prepared by a method known in the pharmaceutical field for use as a therapeutic agent and may be prepared by mixing with a carrier or a pharmaceutically acceptable carrier, a forming agent, . The composition of the present invention can be formulated into preparations for oral or parenteral administration and can be used as a preventive and therapeutic agent for diseases and aging caused by active oxygen. Examples of diseases caused by the active oxygen include degenerative neurological diseases including arteriosclerosis, Lou Gehrig's disease, Parkinson's disease, Alzheimer's disease, proximal axillary sclerosis and Huntington's disease, cardiovascular diseases including myocardial infarction, angina pectoris, coronary artery disease, But are not limited to, digestive system diseases including ischemic brain diseases including diabetes, gastritis and gastric cancer, cancer, leukemia, aging, rheumatoid arthritis, hepatitis, atopic dermatitis and the like.
본 발명에 따른 유효성분의 투여량은 체내에서 활성성분의 흡수도, 제제의 형태, 환자의 연령, 성별 및 상태, 증상의 정도 등에 따라 적절히 선택될 수 있으며, 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 일반적인 투여량은 0.001mg/kg·일~10g/kg·일이다. 본 발명의 조성물은 독성 및 부작용 없이 안전하게 사용할 수 있으므로 예방 목적으로 장기간 복용시에도 안심하고 사용할 수 있다.The dose of the active ingredient according to the present invention can be appropriately selected depending on the degree of absorption of the active ingredient in the body, the form of the preparation, the age, sex and condition of the patient, the degree of symptoms, etc., , And may be administered in divided doses. Typical dosages are 0.001 mg / kg · day to 10 g / kg · day. The composition of the present invention can be safely used without toxicity and side effects, so that it can be safely used for prolonged use for preventive purposes.
또한 본 발명은 100~200℃에서 열처리한 무의 추출물을 포함하는 항산화 식품 조성물에 관한 것이다. 상기 식품 조성물은 건강식품으로서 정제, 캡슐제, 환제 또는 액제 등의 형태로 제형화하여 사용할 수 있으며, 또는 각종 식품류, 음료, 껌, 차, 비타민 복합제의 첨가물로 사용할 수 있다. 특히 유지와 같이 산패가 일어나기 쉬운 음식에 산화방지제로 첨가되어 사용할 수 있다. 상기 무의 추출물은 본 발명의 식품 조성물에 바람직하게는 0.01~100 중량%로 하여 첨가될 수 있다.The present invention also relates to an antioxidant food composition comprising an extract of radish heat-treated at 100 to 200 ° C. The food composition may be used as a health food in the form of tablets, capsules, pills or liquids or may be used as an additive for various foods, beverages, gums, tea, and vitamin complexes. It can be used as an antioxidant in food which is susceptible to rancidity like oil. The extract of radish may be added to the food composition of the present invention in an amount of preferably 0.01 to 100% by weight.
본 발명은 또한 100~200℃에서 열처리한 무의 추출물을 포함하는 항산화 화장료 조성물에 관한 것이다. 본 발명의 조성물은 피부 노화를 유발하고, 주름, 기미 및 주근깨의 생성을 촉진하는 것으로 알려진 활성산소종의 형성을 억제하는 항산화 효과가 우수하므로 미백 및 노화방지 효능을 갖는 화장료로 사용될 수 있다. 본 발명의 화장료 조성물에는 열처리한 무의 추출물이 0.1~100 중량%의 비율로 함유될 수 있다. 상기 조성물은 화장품 분야에서 널리 사용되는 다른 첨가제와 함께 사용될 수 있으며, 스킨, 스킨로션, 스킨소프트너, 스킨토너, 아스트린젠트, 로션, 영양로션, 밀크로션, 모이스쳐로션, 영양크림, 마사지크림, 모이스쳐크림, 핸드크림, 에센스, 영양에센스, 팩, 비누, 클렌징 폼, 클렌징로션, 클렌징크림, 바디클렌저, 바디로션, 샴푸, 유액, 파운데이션, 프레스파우더, 루스파우더, 아이섀도우 등의 제형에 포함될 수 있다. The present invention also relates to an antioxidant cosmetic composition comprising an extract of radish heat-treated at 100 to 200 ° C. The composition of the present invention can be used as a cosmetic having whitening effect and anti-aging effect because it has excellent antioxidative effect which inhibits the formation of active oxygen species which is known to promote skin aging and promote the production of wrinkles, spots and freckles. The cosmetic composition of the present invention may contain a heat-treated radish extract in a proportion of 0.1 to 100% by weight. The composition can be used in combination with other additives widely used in the field of cosmetics and can be used as a skin, a skin lotion, a skin softener, a skin toner, an astringent, a lotion, a nutrition lotion, a milk lotion, a moisturizing lotion, And may be included in formulations such as hand cream, essence, nutritional essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, body cleanser, body lotion, shampoo, milky lotion, foundation, press powder, loose powder, eye shadow.
이상과 같이 본 발명의 조성물에 의하면 간단한 열처리만으로 추출물의 수율 또한 증가하고 무의 항산화성이 현저하게 증가하므로, 의약품이나 화장품 및 식품 분야에서 경제적이면서도 효능이 우수하며 안전한 항산화제로서 유용하게 사용될 수 있다. As described above, according to the composition of the present invention, the yield of the extract is increased only by a simple heat treatment and the antioxidative activity of radish is remarkably increased. Thus, it is economical and effective in pharmaceuticals, cosmetics and foods, and can be effectively used as a safe antioxidant .
도 1은 무의 열처리에 의한 추출물의 폴리페놀 함량의 변화를 보여주는 그래프.
도 2는 무의 열처리에 의한 추출물의 DPPH 라디칼 소거능의 변화를 보여주는 그래프.
도 3은 무의 열처리에 의한 추출물의 ABTS cation decolorization assay의 결과를 보여주는 그래프.FIG. 1 is a graph showing changes in polyphenol content of the extract by heat treatment of radish.
FIG. 2 is a graph showing the change of DPPH radical scavenging ability of the extract by heat treatment of radish.
FIG. 3 is a graph showing the results of the ABTS cation decolorization assay of the extract by heat treatment of radish.
이하 첨부된 실시예를 들어 본 발명을 보다 상세히 설명한다. 그러나 이러한 실시예는 본 발명의 기술적 사상의 내용과 범위를 쉽게 설명하기 위한 예시일 뿐, 이에 의해 본 발명의 기술적 범위가 한정되거나 변경되는 것은 아니다. 이러한 예시에 기초하여 본 발명의 기술적 사상의 범위 안에서 다양한 변형과 변경이 가능함은 당업자에게는 당연할 것이다. Hereinafter, the present invention will be described in more detail with reference to the following examples. However, these embodiments are merely examples for explaining the content and scope of the technical idea of the present invention, and thus the technical scope of the present invention is not limited or changed. It will be apparent to those skilled in the art that various changes and modifications can be made within the scope of the technical idea of the present invention based on these examples.
[실시예][Example]
실시예 1 : 무의 열처리 및 추출물의 제조Example 1: Heat treatment of radish and preparation of extract
1) 무의 열처리1) Heat treatment of radish
농수산물 도매시장에서 버려지는 무를 구입하여 껍질과 무청을 포함하여 세척한 후 사용하였다. Purchased radish from the agricultural and marine wholesale market was washed and washed with shell and wax.
열처리 장치는 10 kg/cm2 이상의 압력에서도 견딜 수 있도록 고안, 제작된 열처리장치(Jisco, Seoul, Korea)를 사용하였다. 무 시료는 통째로 용기에 담은 후, 일정량의 물이 첨가된 외부용기 안에 넣고 정해진 온도와 시간에 따라 가열하는 것에 의해 직접적인 열전달에 의한 시료의 탄화를 방지하였으며, 열처리 과정 중 수증기가 처리될 수 있도록 하였다. 열처리온도는 110, 120, 130, 140 및 150℃로 설정하였고, 열처리 시간은 2시간으로 설정하였다.The heat treatment apparatus (Jisco, Seoul, Korea) designed and manufactured to withstand pressures of 10 kg / cm 2 or more was used. The non-free sample was placed in an outer container filled with a certain amount of water, heated at a predetermined temperature and time to prevent carbonization of the sample due to direct heat transfer, and treated with steam during the heat treatment . The heat treatment temperature was set at 110, 120, 130, 140 and 150 ° C, and the heat treatment time was set at 2 hours.
2) 열처리된 무 추출물의 제조2) Preparation of heat-treated radish extract
열처리된 시료를 냉각한 후, 분쇄기를 사용하여 마쇄하고 10배의(v/v) 70% 에탄올(v/v)을 넣고 환류하며 3시간 추출하였다. 추출액을 여과한 후 농축하여 사용하였다. After the heat-treated sample was cooled, it was ground using a pulverizer, and 10 times (v / v) 70% ethanol (v / v) was added and refluxed for 3 hours. The extract was filtered and concentrated.
비교를 위하여 열처리하지 않은 시료로부터 동일한 방법에 의해 추출물을 제조하여 대조구로 사용하였다. 하기 모든 실험은 3회 반복 하였다.For comparison, extracts were prepared from the untreated samples by the same method and used as a control. All the following experiments were repeated three times.
에탄올 추출물의 수율은 대조구의 4.883 w%에서 열처리 온도가 증가함에 따라 130℃까지는 5.709 w%까지 증가하였으나, 140 및 150℃에서는 각각 5.584와 5.186 w%까지 다시 감소하였다. The yield of ethanol extract increased to 5.709w% up to 130 ℃ as the heat treatment temperature increased from 4.883w% in the control, but decreased again to 5.584 and 5.186w% at 140 and 150 ℃, respectively.
실시예 2 : 열처리된 무의 특성 평가Example 2: Characterization of heat-treated radish
1) 색도 및 갈변도 측정1) Measurement of color and browness
실시예 1에서 각각의 온도에서 열처리한 추출물의 색변화는 색차계(Minolta, CR-200, Tokyo, Japan)를 이용하여 명암도를 나타내는 L값(lightness), 적색도를 나타내는 a값(redness), 황색도를 나타내는 b값(yellowness)을 측정하였다. 갈변도는 열처리 시료 추출물을 15배 희석한 후 spectrophotometer(Shimadzu, UV-1650, PC, Tokyo, Japan)를 이용하여 420nm에서의 흡광도로 측정하였다.The color changes of the extracts heat-treated at the respective temperatures in Example 1 were measured using an L value (lightness) indicating intensity of light, a value (redness) indicating redness, red And the b value (yellowness) indicating the degree of the measurement was measured. The degree of browning was measured by absorbance at 420 nm using a spectrophotometer (Shimadzu, UV-1650, PC, Tokyo, Japan) after 15-fold dilution of the heat-treated sample extract.
하기 표 1은 그 결과를 나타낸 것으로, 색도 중 명도를 나타내는 L값은 열처리 온도가 증가함에 따라 대조구(무처리)의 98.65에서 계속 감소하여 150℃에서는 57.48로 낮아졌다. 적색도를 나타내는 a값은 낮은 열처리 온도에서는 큰 변화가 없었지만(0.34∼1.31) 140℃에서 9.22, 150℃에서는 14.83으로 급격하게 증가하였다. 황색도를 나타내는 b값은 대조구와 110℃에서는 각각 1.54 및 3.96으로 큰 변화가 없었지만 120℃에서는 26.37로 급격하게 증가 한 후 150℃까지는 1.436을 나타내었다. 전체적으로 열처리 온도에 따른 무 에탄올 추출물의 색은 낮은 온도에서는 엷은 갈색을 나타내다가 140℃ 처리부터는 검은색을 나타내었다.Table 1 shows the results. The L value indicating the brightness of the chromaticity was continuously decreased from 98.65 of the control (untreated) to 57.48 at 150 ° C as the heat treatment temperature was increased. The a value of redness showed no significant change at low heat treatment temperature (0.34 ~ 1.31) but increased sharply at 9.22 at 140 ℃ and 14.83 at 150 ℃. The b value indicating the degree of yellowness was not significantly changed to 1.54 and 3.96 at the control and at 110 ° C, but rapidly increased to 26.37 at 120 ° C and 1.436 after 150 ° C. Overall, the color of the ethanol - free extracts showed a light brown color at low temperature and a black color at 140 ℃.
2) 총 폴리페놀 함량 측정2) Total polyphenol content measurement
폴리페놀성 물질이 phosphomolybdic acid와 반응하여 청색을 나타내는 현상을 이용한 Folin-Ciocalteu법(V. Dewamtp 등, J. Agric. Food Chem., 50 (2002), pp. 3010-3014)으로 총 폴리페놀 함량을 측정하였다. 즉, 추출물 100 ㎕에 2% Na2CO3 용액 2 mL를 넣고 3분간 방치한 후, 50% Folin-Ciocalteu 시약 100 ㎕를 가하였다. 암소에서 30분 반응시킨 후, 750 nm에서 흡광도를 측정하여 페놀의 함량을 정량하고 그 결과를 도 1에 도시하였다. 표준물질로는 tannic acid를 사용하였다.The total polyphenol content was measured by the Folin-Ciocalteu method (V. Dewamtp et al., J. Agric. Food Chem., 50 (2002), pp. 3010-3014) using a phenomenon in which a polyphenolic substance reacts with phosphomolybdic acid Were measured. That is, 2 mL of a 2% Na 2 CO 3 solution was added to 100 μL of the extract, and the mixture was allowed to stand for 3 minutes. Then, 100 μL of 50% Folin-Ciocalteu reagent was added thereto. After reacting in a dark place for 30 minutes, the absorbance at 750 nm was measured to determine the content of phenol. The results are shown in FIG. Tannic acid was used as a reference material.
도 1에서 확인할 수 있듯이, 추출물 중 폴리페놀의 함량은 열처리에 의해 급격히 증가하여 150℃에서의 열처리 시 대조구에 비해 22배 이상이 증가하였으며, 110℃에서의 열처리구에 비해서도 6.7배 정도가 증가하였다.As shown in FIG. 1, the content of polyphenol in the extract rapidly increased by heat treatment, which was 22 times higher than that of the control at 150 ° C. and 6.7 times higher than that of the heat treated at 110 ° C. .
3) DPPH 라디칼 소거능 측정3) Measurement of DPPH radical scavenging ability
추출물에 0.8 mL의 0.02 mM DPPH(1,1-diphenyl-2-picryl hydrazyl, Sigma Aldrich) 용액을 가하였다. 혼합물을 vortex mixer로 10초간 진탕하고 30분간 실온에서 방치한 뒤, 분광광도계(Beckman Coulter, DU-650, Anaheim, CA, USA)를 이용하여 525nm에서 흡광도를 측정하였다. 추출물의 농도에 따른 라디칼 소거능(%)을 다음 식으로 계산한 후 50%의 라디칼 소거능을 나타내는 농도(IC50)를 구하여 그 결과를 도 2에 도시하였다.0.8 mL of 0.02 mM DPPH (1,1-diphenyl-2-picryl hydrazyl, Sigma Aldrich) solution was added to the extract. The mixture was shaken for 10 seconds with a vortex mixer and allowed to stand at room temperature for 30 minutes. Absorbance was measured at 525 nm using a spectrophotometer (Beckman Coulter, DU-650, Anaheim, CA, USA). The radical scavenging activity (%) according to the concentration of the extract was calculated by the following equation, and the concentration (IC 50 ) exhibiting a radical scavenging activity of 50% was determined. The results are shown in FIG.
상기 수식에서 Abssample는 시료의 흡광도를 나타내며, Absst는 추출물 시료를 포함하지 않는 용액의 흡광도를 의미한다.In the above equation, Abs sample represents the absorbance of the sample, and Abs st represents the absorbance of the solution containing no extract sample.
DPPH 라디칼 소거능은 무의 열처리 온도에 의존적으로 증가하였으며, 110℃에서 열처리한 무에 비해 150℃에서 열처리한 무는 IC50 값이 1/22 수준으로 감소하여 항산화 효능이 크게 증가함을 보여주었다. 도 2에 도시하지는 않았으나, 대조구의 IC50 값은 130.305로 150℃에서 열처리한 무에 비해 234배에 달하였다.DPPH radical scavenging activity was increased by heat treatment depends on the temperature of the fog, and the biting by IC 50 value, the heat treatment at 150 ℃ compared to the non-heat-treated at 110 ℃ reduced to 1/22 level showed a significantly increased antioxidant effect. Although not shown in FIG. 2, the IC 50 value of the control was 130.305, which was 234 times that of the heat treated at 150 ° C.
4) ABTS cation decolorization assay4) ABTS cation decolorization assay
각 추출물의 총 항산화력을 ABTS.+ cation decolorization assay 방법에 의하여 측정하였다. 7.4 mM 2,2'-Azino-bis-(3-ethylbenozothiazoline-6-sulfonic acid) (ABTS)와 2.6 mM potassium persulphate를 하루동안 암소에서 방치하여 ABTS.+ 양이온을 형성시킨 후 이 용액을 735 nm에서 흡광도 값이 1.4∼1.5가 되도록 물 흡광계수(ε=3.6×104 M-1cm-1)를 이용하여 증류수로 희석하였다. 희석된 ABTS.+ 용액 1 mL에 추출액 50 μL을 가하여 흡광도의 변화를 정확히 60분 후에 측정하였다. 표준물질로서 L-ascorbic acid (Sigma Aldrich)를 사용하여 AEAC(ascorbic acid equivalent antioxidant capacity)로 나타내었다.Total antioxidant capacity of each extract was measured by ABTS . + Cation decolorization assay. (ABTS) and 2.6 mM potassium persulphate were incubated overnight in the dark to form ABTS . + Cations . The solution was incubated at 735 nm And diluted with distilled water using a water extinction coefficient (? = 3.6 × 10 4 M -1 cm -1 ) such that the absorbance value is 1.4 to 1.5. To 1 mL of diluted ABTS . + Solution, 50 μL of extract was added and the change in absorbance was measured after 60 minutes. L-ascorbic acid (Sigma Aldrich) was used as a reference material and expressed as ascorbic acid equivalent antioxidant capacity (AEAC).
도 3은 그 결과를 나타내는 그래프로, 폴리페놀이나 DPPH 라디칼 소거능과 마찬가지로 열처리 온도가 증가함에 따라 항산화능이 온도 의존적으로 증가하였다. 150℃에서 열처리한 경우, 대조구에 비해 ABTS assay에 의한 항산화력이 약 23배 정도 증가하였다.FIG. 3 is a graph showing the results. As in the case of the polyphenol and DPPH radical scavenging ability, the antioxidant activity was increased in a temperature-dependent manner as the heat treatment temperature was increased. When heat treated at 150 ℃, the antioxidative capacity by ABTS assay was increased about 23 times as compared with the control.
Claims (8)
An antioxidant pharmaceutical composition comprising an extract of radish heat-treated at 100 to 200 ° C.
상기 무는 생것, 건조물 또는 동결물인 것을 특징으로 하는 항산화 약학 조성물.
The method according to claim 1,
The antioxidative pharmaceutical composition according to any one of claims 1 to 3, wherein the bittern is raw, dried or frozen.
상기 무는 무의 뿌리 또는 무청 또는 이들의 혼합물인 것을 특징으로 하는 항산화 약학 조성물.
The method according to claim 1,
Wherein said radish is root, radish or mixture thereof.
상기 열처리 시간은 10분~6시간인 것을 특징으로 하는 항산화 약학 조성물.
4. The method according to any one of claims 1 to 3,
Wherein the heat treatment time is from 10 minutes to 6 hours.
상기 추출물은 물 또는 C1~C4의 알콜 또는 이들의 혼합물을 사용하여 열처리한 무를 추출한 것을 특징으로 하는 항산화 약학 조성물.
4. The method according to any one of claims 1 to 3,
Wherein the extract is obtained by extracting radish heat-treated with water, C1-C4 alcohol or a mixture thereof.
상기 항산화 약학 조성물은 활성산소로 인해 발생하는 동맥경화증, 루게릭병, 파킨슨병, 알츠하이머, 근위축색경화증 및 헌팅톤병을 포함하는 퇴행성 신경질환, 심근경색, 협심증, 관상동맥질환, 허혈성 심장질환을 포함하는 심혈관 질환, 뇌졸중을 포함하는 허혈성 뇌질환, 당뇨병, 위염 및 위암을 포함하는 소화기계 질환, 암, 백혈병, 노화, 류마티스 관절염, 간염, 아토피성 피부염 또는 노화의 예방 및 치료를 위한 것임을 특징으로 하는 항산화 약학 조성물.
4. The method according to any one of claims 1 to 3,
The antioxidant pharmaceutical composition may be used for the treatment or prevention of atherosclerotic diseases including, but not limited to, arteriosclerosis caused by active oxygen, degenerative neurological diseases including Lou Gehrig's disease, Parkinson's disease, Alzheimer's disease, proximal axillary sclerosis and Huntington's disease, myocardial infarction, angina pectoris, coronary artery disease, Wherein said antioxidant is for the prevention and treatment of gastrointestinal diseases including cardiovascular diseases and ischemic brain diseases including stroke, diabetes, gastritis and gastric cancer, cancer, leukemia, aging, rheumatoid arthritis, hepatitis, atopic dermatitis or aging A pharmaceutical composition.
An antioxidant food composition comprising an extract of radish heat-treated at 100 to 200 ° C.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170125436A KR20190036330A (en) | 2017-09-27 | 2017-09-27 | Anti-oxidant Composition Comprising Heated Radish Extract |
AU2017265146A AU2017265146A1 (en) | 2017-09-27 | 2017-11-24 | Antioxidant composition comprising heated radish extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170125436A KR20190036330A (en) | 2017-09-27 | 2017-09-27 | Anti-oxidant Composition Comprising Heated Radish Extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190036330A true KR20190036330A (en) | 2019-04-04 |
Family
ID=66038696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170125436A KR20190036330A (en) | 2017-09-27 | 2017-09-27 | Anti-oxidant Composition Comprising Heated Radish Extract |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20190036330A (en) |
AU (1) | AU2017265146A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210035483A (en) * | 2019-09-24 | 2021-04-01 | 신경식 | Composition for cultivating strawberry using Spirulina |
WO2021133006A1 (en) * | 2019-12-24 | 2021-07-01 | 제주돌담뜰 농업회사법인(주) | Composition, for reducing skin wrinkles or preventing skin aging, containing dried and roasted radish extract and functional health food comprising composition |
KR20230126758A (en) | 2022-02-23 | 2023-08-31 | 서원대학교산학협력단 | Complex Extract Composition with Improved Antioxidant Activity |
KR20230142002A (en) | 2022-03-30 | 2023-10-11 | 서원대학교산학협력단 | Fruit-Vegetable Complex Extract Composition with Improved Antioxidant Activity Comprising Red Ginseng |
KR20230141999A (en) | 2022-03-30 | 2023-10-11 | 서원대학교산학협력단 | Fruit-Vegetable Complex Extract Composition with Improved Antioxidant Activity |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101338190B1 (en) | 2012-01-06 | 2013-12-09 | 임종복 | Pharmaceutical and Food composition comprising the antioxidant juice of bordeaux radish Raphanus sativus L. for prevention or control of thrombosis |
KR101685251B1 (en) | 2014-05-28 | 2016-12-09 | 가천대학교 산학협력단 | Cosmetic composition comprising extract of Brassica Rapa, Brassica Rapa radish leaves or Brassica Rapa callus with anti-oxidant, astringent activity and skin wrinkle improvement effect and the manufacturing method thereof |
KR101706817B1 (en) | 2014-04-18 | 2017-02-16 | 지수진 | Composition comprising radish leave extract for anti-inflammatory and anti-oxidant |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030016560A (en) * | 2001-08-21 | 2003-03-03 | 한영환 | Isolation and utility of whitenings and antioxidants from Raphanus sativus |
US20040175444A1 (en) * | 2002-12-12 | 2004-09-09 | Soon-Ok Baik | Crude drug compositions and the process for preparing them |
KR100889232B1 (en) * | 2007-07-25 | 2009-03-16 | 장승수 | Beverage of Raphanus sativus L. and the manufacturing method thereof |
KR100970872B1 (en) * | 2009-11-27 | 2010-07-20 | 오정숙 | Seasoning sauce for baek kimchi and baek kimchi seasoned with the same |
CN104306552A (en) * | 2014-10-13 | 2015-01-28 | 吴冬梅 | Preparation method of contact dermatitis treating medicine |
CN106605739A (en) * | 2016-11-07 | 2017-05-03 | 吴伟 | Tea beverage used for preventing and controlling infectious diseases and preparation method thereof |
-
2017
- 2017-09-27 KR KR1020170125436A patent/KR20190036330A/en active Search and Examination
- 2017-11-24 AU AU2017265146A patent/AU2017265146A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101338190B1 (en) | 2012-01-06 | 2013-12-09 | 임종복 | Pharmaceutical and Food composition comprising the antioxidant juice of bordeaux radish Raphanus sativus L. for prevention or control of thrombosis |
KR101706817B1 (en) | 2014-04-18 | 2017-02-16 | 지수진 | Composition comprising radish leave extract for anti-inflammatory and anti-oxidant |
KR101685251B1 (en) | 2014-05-28 | 2016-12-09 | 가천대학교 산학협력단 | Cosmetic composition comprising extract of Brassica Rapa, Brassica Rapa radish leaves or Brassica Rapa callus with anti-oxidant, astringent activity and skin wrinkle improvement effect and the manufacturing method thereof |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210035483A (en) * | 2019-09-24 | 2021-04-01 | 신경식 | Composition for cultivating strawberry using Spirulina |
WO2021133006A1 (en) * | 2019-12-24 | 2021-07-01 | 제주돌담뜰 농업회사법인(주) | Composition, for reducing skin wrinkles or preventing skin aging, containing dried and roasted radish extract and functional health food comprising composition |
KR20230126758A (en) | 2022-02-23 | 2023-08-31 | 서원대학교산학협력단 | Complex Extract Composition with Improved Antioxidant Activity |
KR20230142002A (en) | 2022-03-30 | 2023-10-11 | 서원대학교산학협력단 | Fruit-Vegetable Complex Extract Composition with Improved Antioxidant Activity Comprising Red Ginseng |
KR20230141999A (en) | 2022-03-30 | 2023-10-11 | 서원대학교산학협력단 | Fruit-Vegetable Complex Extract Composition with Improved Antioxidant Activity |
Also Published As
Publication number | Publication date |
---|---|
AU2017265146A1 (en) | 2019-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Nutritional values, beneficial effects, and food applications of broccoli (Brassica oleracea var. italica Plenck) | |
KR20190036330A (en) | Anti-oxidant Composition Comprising Heated Radish Extract | |
JP4358957B2 (en) | Agent for scavenging or reducing free radicals or active oxygen | |
Taha et al. | Comparison between antioxidant activities of phenolic extracts from different parts of peanut | |
Kutlu et al. | DNA damage protecting activity and in vitro antioxidant potential of the methanol extract of Cherry (Prunus avium L) | |
KR20200053014A (en) | Anti-oxidant composition comprising the mixed extract of vegetable natural products having the effect on removal of swelling | |
KR20190072937A (en) | Antioxidant functional beverage and food composition comprising the extract of edible flowers and preparation method of the same | |
Taha et al. | Evaluation of the biological activity of sunflower hull extracts | |
KR20190057225A (en) | A composition having anti-oxidation or anti-inflammation comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
Lee et al. | Antioxidative activities of the ethyl acetate fraction from heated onion (Allium cepa) | |
KR20160021734A (en) | Antioxidative composition comprising extract of red tea stem | |
KR102298042B1 (en) | Composition for antioxidant and anti-inflammatory comprising extract of pepper seeds | |
KR101004361B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
KR101063351B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
KR102511666B1 (en) | Processing technology for increasing bioactive compounds in potato | |
Dangal et al. | A comprehensive review on study of physical, nutritional, and phytochemical characteristics as well as therapeutic activities of Choerospondias axillaris (lapsi) | |
KR102137470B1 (en) | Anti-oxidant and anti-inflammatory composition comprising a pear processing byproducts, and manufacturing method thereof | |
KR20180098737A (en) | A composition having anti-oxidation or anti-inflammation comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR101952006B1 (en) | Soap composition comprising extracts of rosa rugosa and preparation method thereof | |
KR101171846B1 (en) | Post-harvest Amplification Method of Active Compounds in Brassicaceae Vegetables Using High Hydrostatic Pressure and Brassicaceae Vegetables Treated with the Same Method | |
Ademiluyi et al. | Effects of cooking on phenolic content and antioxidant properties of African walnut Tetracarpidium conophorum (Müll. Arg.) Hutch. & Dalziel. Seeds | |
KR101661321B1 (en) | A composition for preventing hyperlipidemia and obesity, manufacturing method thereof and health functional food comprising the same | |
KR101007001B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
KR101889431B1 (en) | Pharmaceutical composition for antioxidation comprising black burdock root extracts as an effective component | |
KR102129461B1 (en) | A composition having anti-bacterial activity comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment |